Literature DB >> 22256996

Topical timolol for infantile hemangiomas: putting a note of caution in "cautiously optimistic".

Patrick McMahon1, Vikash Oza, Ilona J Frieden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22256996     DOI： 10.1111/j.1525-1470.2011.01685.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.588


× No keyword cloud information.
  9 in total

1.  Topical Timolol for Paronychia and Pseudopyogenic Granuloma in Patients Treated With Epidermal Growth Factor Receptor Inhibitors and Capecitabine.

Authors:  Xavier Cubiró; Sergi Planas-Ciudad; Mª Pilar Garcia-Muret; Lluís Puig
Journal:  JAMA Dermatol       Date:  2018-01-01       Impact factor: 10.282

2.  Absorption and Safety of Topically Applied Timolol for Treatment of Chronic Cutaneous Wounds.

Authors:  Anthony Cole Gallegos; Michael James Davis; Catherine N Tchanque-Fossuo; Kaitlyn West; Angela Eisentrout-Melton; Thomas R Peavy; Roy W Dixon; Roma P Patel; Sara Evona Dahle; Roslyn Rivkah Isseroff
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-10-16       Impact factor: 4.730

3.  Efficacy of low-dose 90Sr-90Y therapy combined with topical application of 0.5% timolol maleate solution for the treatment of superficial infantile hemangiomas.

Authors:  Hong-Jian Zhu; Qinghong Liu; Xiao-Li Deng; Yan-Xing Guan
Journal:  Exp Ther Med       Date:  2015-07-01       Impact factor: 2.447

Review 4.  Treatment of infantile haemangiomas: recommendations of a European expert group.

Authors:  Peter H Hoeger; John I Harper; Eulalia Baselga; Damien Bonnet; Laurence M Boon; Marta Ciofi Degli Atti; Maya El Hachem; Arnold P Oranje; Agneta Troilius Rubin; Lisa Weibel; Christine Léauté-Labrèze
Journal:  Eur J Pediatr       Date:  2015-05-29       Impact factor: 3.183

Review 5.  Beta blockers: an innovation in the treatment of infantile hemangiomas.

Authors:  Shehla Admani; Stephanie Feldstein; Ernesto M Gonzalez; Sheila Fallon Friedlander
Journal:  J Clin Aesthet Dermatol       Date:  2014-07

Review 6.  Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.

Authors:  Daniel J Yoon; Ramanjot Kaur; Anthony Gallegos; Kaitlyn West; Hsinya Yang; Saul Schaefer; Catherine Tchanque-Fossuo; Sara E Dahle; R Rivkah Isseroff
Journal:  Am J Clin Dermatol       Date:  2020-11-25       Impact factor: 7.403

7.  Topical Timolol Inhibits Corneal Neovascularization in Rabbits.

Authors:  Ali Kasiri; Mehdi Reza Ghomi; Mostafa Feghhi; Fereydoun Farrahi; Mohammad Sadegh Mirdehghan; Hesam Hedayati
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2017

8.  Colon adenocarcinoma-derived cells possessing stem cell function can be modulated using renin-angiotensin system inhibitors.

Authors:  Matthew J Munro; Lifeng Peng; Susrutha K Wickremesekera; Swee T Tan
Journal:  PLoS One       Date:  2021-08-24       Impact factor: 3.240

9.  Oral propranolol combined with topical timolol for compound infantile hemangiomas: a retrospective study.

Authors:  Jing Ge; Jiawei Zheng; Ling Zhang; Weien Yuan; Haiguang Zhao
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.